⌘K
Sham Foam is engaged in the business of manufacturing, distribution, and marketing, likely within the mattress industry, as indicated by the addressable market data. The company has demonstrated strong financial growth and profitability in recent years.
Deterministic verdict 'Neutral': listing=58/Neutral, short=70/Neutral Positive, long=72/Apply; overall=69.3; confidence=81.0/100 | computed financials: fin=86, growth=78, D/E=0.19 (70% math / 30% model) | market signals: alignment=n/a (OFS None%), anchor quality=n/a (marquee None%), GMP trend=fading, overhang=n/a | rule: mixed signals -> Neutral. | Analyst notes: Sham Foam demonstrates exceptional financial health with strong growth in revenue and profits, coupled with outstanding return ratios (ROE, ROCE) and a very low debt profile. The post-IPO valuation is attractive when compared to its peers, suggesting a potential for significant upside. While there is a notable lack of detailed qualitative information in the DRHP, which is a common characteristic of SME IPOs, the robust quantitative performance and strategic use of IPO funds for expansion provide a strong foundation. The weak market sentiment, as indicated by the absence of QIB subscription and low GMP, might limit immediate listing gains but presents a compelling entry point for long-term investors focused on fundamentals. The high promoter holding further reinforces confidence in the company's future.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| NII (HNI) | 14,79,000 | 47.5% | |
| Retail | 14,79,000 | 47.5% | |
| Market Maker | 1,56,000 | 5.01% |
Strong financial performance with consistent revenue, EBITDA, and PAT growth.
Exceptional return ratios (ROE 51.53%, ROCE 45.73%).
Very low debt-to-equity ratio (0.19).
Attractive valuation (Post-IPO P/E 17.26x) compared to peers.
High promoter holding (72.9% post-IPO) indicating strong commitment.
IPO proceeds earmarked for capital expenditure and working capital, supporting future growth.
Operating in a growing industry (India mattress market CAGR 8.8%).
Successful implementation of capex plans, increasing market share in the growing mattress industry, and improved brand recognition.
Steady demand in the domestic market, efficient utilization of IPO funds, and stable raw material prices.
Intensified competition, failure to effectively deploy IPO funds, or adverse changes in consumer spending patterns.
Despite strong fundamentals and attractive valuation, the weak market sentiment (low GMP, no QIB interest) suggests limited listing pop. However, the attractive pricing might attract some short-term interest.
The company's strong financial performance, high return ratios, and attractive valuation relative to peers make it a compelling short-term investment, assuming market sentiment improves post-listing.
The company operates in a growing industry, has demonstrated strong financial growth, and is using IPO funds for expansion. Its robust profitability and low debt position it well for sustained long-term growth, provided it can overcome the current information asymmetry.
Final verdict: Neutral (confidence High).
Positive: Consistent and strong revenue, EBITDA, and PAT growth (FY24-FY26).
Concern: Lack of detailed business description, competitive analysis, and risk factors in the DRHP.
Listing-gain vs long-term: Neutral / Apply.
Concern: Absence of QIB subscription data.